Publicaciones (160) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Corrigendum to “European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO” [Eur J Surg Oncol 50 (1) (January 2024) 107292] (European Journal of Surgical Oncology (2024) 50(1), (S0748798323009307), (10.1016/j.ejso.2023.107292))

    European Journal of Surgical Oncology

  2. Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer

    Seminars in Oncology Nursing, Vol. 40, Núm. 1

  3. Dendritic Cells in Cancer Immunology and Immunotherapy

    Cancers, Vol. 16, Núm. 5

  4. EUSOMA quality indicators for non-metastatic breast cancer: An update

    European Journal of Cancer, Vol. 198

  5. European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO

    European Journal of Surgical Oncology, Vol. 50, Núm. 1

  6. Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)

    European Journal of Nuclear Medicine and Molecular Imaging

  7. Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines

    European Journal of Nuclear Medicine and Molecular Imaging

  8. Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature

    Journal of Clinical Oncology, Vol. 42, Núm. 10, pp. 1124-1134

  9. Long-term results of intraoperative multicatheter breast implant (IOMBI) for accelerated partial breast irradiation (APBI) on early breast cancer patients

    Radiotherapy and Oncology, Vol. 194

  10. Post- versus intra-operative implant for breast cancer interstitial brachytherapy: How to choose?

    Journal of Contemporary Brachytherapy, Vol. 16, Núm. 1, pp. 72-83

  11. Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line

    Clinical and Translational Oncology

  12. Treatment and outcomes in breast cancer patients: A cross section study from the EUSOMA breast centre network

    European Journal of Cancer, Vol. 196

  13. Very accelerated partial breast irradiation in 1 or 2 days: Late toxicity and early oncological outcome of the GEC-ESTRO VAPBI cohort

    Radiotherapy and Oncology, Vol. 194

2023

  1. Axillary staging and management of cN + breast cancer patients treated with neoadjuvant chemotherapy: results of a survey among breast cancer surgeons in Spain

    Clinical and Translational Oncology, Vol. 25, Núm. 5, pp. 1463-1471

  2. Delays to surgery following chemoradiotherapy lead to poorer oncologic outcomes in patients with localized pancreatic adenocarcinoma

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 8, pp. 428-434

  3. EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy

    European Journal of Cancer, Vol. 181, pp. 79-91

  4. European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

    The Lancet Oncology, Vol. 24, Núm. 1, pp. e11-e56

  5. European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care

    European Journal of Cancer, Vol. 187, pp. 105-113

  6. Evolution and refinement of magnetically guided sentinel lymph node detection in breast cancer: meta-analysis

    The British journal of surgery, Vol. 110, Núm. 4, pp. 410-419

  7. Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment

    European Journal of Surgical Oncology, Vol. 49, Núm. 10